GW Pharmaceuticals Plc American Depositary Shares
GWPH
GWPH was delisted on the 4th of May, 2021.
109 hedge funds and large institutions have $1.22B invested in GW Pharmaceuticals Plc American Depositary Shares in 2015 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 36 increasing their positions, 25 reducing their positions, and 18 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
44% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 25
33% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 18
5% more funds holding
Funds holding: 104 → 109 (+5)
24% less capital invested
Capital invested by funds: $1.62B → $1.22B (-$395M)
56% less call options, than puts
Call options by funds: $47.2M | Put options by funds: $106M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OppenheimerFunds
New York
|
+$122M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$36.1M |
| 3 |
HCM
Hayman Capital Management
Dallas,
Texas
|
+$23.4M |
| 4 |
LCP
Lamond Capital Partners
San Francisco,
California
|
+$13.3M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$10.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$29.5M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$17.9M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$12M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$8.09M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$7.37M |
GWPH Hedge Fund Activity: Q3 2015 in Review
109 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q3 2015, worth a combined $1.22B — down 24% from $1.62B a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new GWPH positions and 18 closed out — a net gain of 6 holders — while 36 added to existing stakes and 25 trimmed.
The largest buyer was OppenheimerFunds, adding an estimated $122M. The largest seller was Federated Hermes, cutting an estimated $29.5M.
- 109 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q3 2015, up from 104 in Q2 2015.
- Funds reported $1.22B of GW Pharmaceuticals Plc American Depositary Shares stock for Q3 2015, down 24% quarter-over-quarter.
- 24 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q3 2015 and 18 closed out, a net change of +6 holders.
- The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q3 2015 was OppenheimerFunds, an estimated $122M added.
- The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q3 2015 was Federated Hermes, an estimated $29.5M sold.
Based on aggregated 13F filings for Q3 2015.